On February 8, 2018 Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, reported that it will webcast a business overview and update by Randall C. Schatzman, Ph.D., president and chief executive officer at each of the following upcoming healthcare conferences (Press release, Alder Biopharmaceuticals, FEB 8, 2018, View Source [SID1234524148]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Leerink Partners 7th Annual Global Healthcare Conference at 10:00 a.m. ET on Thursday, February 15, 2018 in New York, NY.

RBC Capital Markets 2018 Healthcare Conference at 9:30 a.m. ET on Wednesday, February 21, 2018 in New York, NY.
A live audio webcast of each event can be accessed on the Events & Presentations page of the Investors section of Alder’s website at View Source, or by following the link below in your web browser. An archived replay of the webcast will be available on Alder’s website for at least 30 days after the live event concludes.

Leerink Link: View Source
RBC Link: https://www.veracast.com/webcasts/rbc/healthcare2018/79104202338.cfm